Search

everythinglearnresearchcommunity

for

Search:↓

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Medicines that lower androgen levels and hair removal treatments help manage excessive hair and acne in women with PCOS.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

Oral retinoids are effective for severe skin conditions but require careful use due to side effects.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Myositis in lupus patients is linked to skin rash, hair loss, blood issues, and high disease activity.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Early diagnosis and treatment can prevent or delay frontal fibrosing alopecia progression in postmenopausal women.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

The method safely and efficiently delivers genes to the skin but may not work for conditions needing high levels of gene products.

Dermatological conditions are complex and treatments often have mixed results.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

The document concludes that accurate diagnosis is crucial for effectively treating common scalp disorders, which often have similar symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

A patient with pemphigus vulgaris improved significantly after treatment for an additional viral skin infection.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

The document concludes that the skin is a complex organ providing protection, sensation, and healing, with challenges in treating conditions like itchiness.

A woman with lupus had blood cell destruction, treated successfully with medication.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Hair loss in lupus patients indicates higher disease activity.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.